Urinary Cell Cycle Arrest Biomarkers and Diuretic Efficiency in Acute Heart Failure

Gonzalo Núñez-Marín, Gregorio Romero-González, Jordi Bover, Jose Luis Górriz, Antoni Bayés-Genís, Juan Sanchis, Julio Núñez, Rafael De La Espriella

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

Resum

Introduction: This study aimed to evaluate the association between the NephroCheck® test AKIRisk® score, diuretic efficiency (DE), and the odds of worsening kidney function (WKF) within the first 72 h of admission in patients hospitalized for acute heart failure (AHF). Methods: The study prospectively enrolled 125 patients admitted with AHF. NephroCheck® test was obtained within the first 24 h of admission. DE was defined as net fluid urine output per 40 mg of furosemide equivalents. Results: The median AKIRisk® score was 0.11 (IQR 0.06-0.34), and 38 (30.4%) patients had an AKIRisk® score >0.3. The median cumulative DE at 72 h was 1,963 mL (IQR 1317-3,239 mL). At 72 h, a total of 10 (8%) patients developed an absolute increase in sCr =0.5 mg/dL (WKF). In a multivariable setting, there was an inverse association between the AKIRisk® score and DE within the first 72 h. In fact, the highest the AKIRisk® score (centered at 0.3), the higher the likelihood of poor DE (below the median) and WKF at 72 h (odds ratio [OR] 2.04; 95%; CI: 1.02-4.07; p = 0.043, and OR 3.31, 95% CI: 1.30-8.43; p = 0.012, respectively). Conclusion: In patients with AHF, a higher NephroCheck® AKIRisk® score is associated with poorer DE and a higher risk of WKF at 72 h. Further research is needed to confirm the role of urinary cell cycle arrest biomarkers in the AHF scenario.
Idioma originalAnglès
Pàgines (de-a)261-269
Nombre de pàgines9
RevistaCardioRenal Medicine
Volum14
Número1
DOIs
Estat de la publicacióPublicada - 2024

Fingerprint

Navegar pels temes de recerca de 'Urinary Cell Cycle Arrest Biomarkers and Diuretic Efficiency in Acute Heart Failure'. Junts formen un fingerprint únic.

Com citar-ho